Johan Nilsson

Johan Nilsson (MD, PhD) is a resident physician specializing in clinical pharmacology and has been working with CTC since 2020. He has experience as principal investigator and co-investigator in more than 50 clinical trials in all phases, including First-in-Human (FIH).

Johan has a special interest in psychiatry, in particular treatment of affective disorders, and education. He has a PhD in psychiatric epidemiology and he is a serving board member and chairman of Kognio^TM, a prominent Swedish centre for education and training in Cognitive Behavioral Therapy (CBT).

• Agreement between self-reports, proxy-reports and the National Patient Register regarding diagnoses of cardiovascular disorders and diabetes mellitus in a population-based sample of 80-year-olds
  juni 21, 2019
• The Gothenburg H70 Birth cohort study 2014-16: design, methods and study population
  november 14, 2018
• Changes in the expression of worries, anxiety, and generalized anxiety disorder with increasing age: A population study of 70 to 85-year-olds
  oktober 25, 2018
• NINE-YEAR FOLLOW-UP OF SPECIFIC PHOBIA IN A POPULATION SAMPLE OF OLDER PEOPLE
  december 10, 2015
• The 1-month prevalence of generalized anxiety disorder according to DSM-IV, DSM-V, and ICD-10 among nondemented 75-year-olds in Gothenburg, Sweden
  maj 3, 2012